Introduction
Recurrent aphthous stomatitis (RAS) is a common oral mucosal disease characterized by recurrent and painful ulcerations on the movable and nonkeratinized oral mucosae. The prevalence of RAS is 10.5% in the general population in Taiwan. 1 The exact causes of RAS are still not very clear, although several etiological factors have been shown to be related to RAS. 2, 3 The finding of a mononuclear cell infiltrate in the subepithelial connective tissue of RAS specimens favor the role of cell-mediated cytotoxicity in the immunopathogenesis of RAS. 3 In addition to dysregulation of immune function, multiple nutritional deficiencies including deficiencies of vitamins B1, B2, B6, and B12, folate, iron, and ferritin are reported to be the possible etiologies of RAS. 3 Our previous studies showed that 57 (20.9%), 55 (20.1%), 13 (4.8%) and 7 (2.6%) of 273 RAS patients have deficiencies of hemoglobin (Hb), iron, vitamin B12, and folic acid, respectively. 3 We also demonstrated that 13.0%, 19.4%, and 19.7% of 355 RAS patients had the presence of anti-gastric parietal cell (GPCA), anti-thyroglobulin (TGA), and antithyroid microsomal autoantibodies (TMA) in their sera, respectively. 4 GPCA can induce destruction of gastric parietal cells, resulting in failure of intrinsic factor production. 5, 6 Intrinsic factor deficiency may cause insufficient absorption of vitamin B12 that finally leads to the status of pernicious anemia (PA). 7, 8 Because multiple factors are involved in Hb deficiency (anemia) in RAS patients, it is interesting to know what factors are most important for the development of anemia or hematinic deficiencies in TGApositive and/or TMA-positive (TGA/TMA-positive) RAS patients with GPCA positivity (GPCAþ/TGA/TMA/RAS patients) or negativity (GPCAÀ/TGA/TMA/RAS patients).
In our oral mucosal disease clinic, patients with atrophic glossitis (AG), burning mouth syndrome (BMS), oral lichen planus (OLP), RAS, oral submucous fibrosis (OSF), and other oral mucosal diseases are frequently encountered. 3,4,9e28 For AG, BMS, OLP, RAS and OSF patients, complete blood count, serum iron, vitamin B12, folic acid, homocysteine, anti-nuclear antibody (ANA), anti-smooth muscle antibody (SMA), anti-mitochondrial antibody (AMA), GPCA, TGA, and TMA levels were often examined to evaluate whether these patients have anemia, hematinic deficiencies and serum ANA, SMA, AMA, GPCA, TGA, or TMA positivity. 3,4,9e25 Our previous studies discovered that 16 14, 17 To assess whether the serum GPCA, TGA, and TMA as well as the disease of RAS itself played significant roles in causing anemia and hematinic deficiencies in GPCAþ/TGA/TMA/RAS patients or GPCAÀ/TGA/TMA/RAS patients, 15 GPCAþ/TGA/TMA/RAS patients without ANA, SMA, and AMA positivities, 69 GPCAÀ/TGA/TMA/RAS patients without ANA, SMA, and AMA positivities, and 240 all six aforementioned autoantibodies-negative RAS patients (AbsÀ/RAS patients) were collected and included in this study. Their complete blood counts as well as serum iron, vitamin B12, folic acid, and homocysteine levels were examined and compared with the corresponding data of 342 healthy control subjects. The purposes of this study were to study the anemia statuses and hematinic deficiencies in these 15 GPCAþ/TGA/TMA/RAS patients and 69 GPCAÀ/ TGA/TMA/RAS patients and to further clarify the roles of the serum GPCA, TGA, TMA and/or the disease of RAS itself in the final development of anemia and hematinic deficiencies in our GPCAþ/TGA/TMA/RAS and GPCAÀ/TGA/ TMA/RAS patients.
Materials and methods

Subjects
This study included 84 (18 men and 66 women, age range 26e83 years, mean age 54.5 AE 13.7 years) TGA/TMA/RAS patients, 240 (78 men and 162 women, age range 18e90 years, mean 50.9 AE 16.3 years) AbsÀ/RAS patients, and 342 healthy control subjects (104 men and 238 women, age range 20e89 years, mean 52.7 AE 14.7 years). The 84 TGA/TMA/RAS patients were further divided into 15 (3 men and 12 women, age range 47e71 years, mean age 61.2 AE 8.0 years) GPCAþ/TGA/TMA/RAS patients and 69 (15 men and 54 women, age range 26e83 years, mean age 53.1 AE 14.3 years) GPCAÀ/TGA/TMA/RAS patients. Patients were diagnosed as having RAS when they had at least one episode of oral ulcerations on movable oral mucosa per month since childhood. 3 RAS patients with betel quid chewing habit or autoimmune diseases (such as systemic lupus erythematosus, rheumatoid arthritis, Sjogren's syndrome, pemphigus vulgaris, and cicatricial pemphigoid) were excluded. Moreover, patients with traumatic ulcers or with aphthous-like ulcers associated with systemic disorders including Behcet's syndrome, celiac disease, gluten-sensitive enteropathy, inflammatory bowel diseases, human immunodeficiency virus infection, and cyclic neutropenia were also excluded. 29 In addition, RAS patients with serum creatinine concentrations indicative of renal dysfunction (i.e., men, >131 mmol/L; women, >115 mmol/ L), and who reported a history of stroke, heavy alcohol use, or diseases of the liver, kidney, or coronary arteries were also excluded. 30 Healthy control subjects had either dental caries, pulpal disease, malocclusion, or missing of teeth but did not have any oral mucosal or systemic diseases. None of the RAS patients had taken any prescription medication for RAS at least 3 months before entering the study.
The blood samples were drawn from all included RAS patients and healthy control subjects for measurement of complete blood count, serum iron, vitamin B12, folic acid, and homocysteine concentrations as well as serum ANA, SMA, AMA, GPCA, TGA, and TMA levels. All RAS patients and healthy control subjects signed the informed consents before entering the study. This study was reviewed and approved by the Institutional Review Board at the National Taiwan University Hospital (NTUH).
Determination of complete blood count and serum iron, vitamin B12, folic acid and homocysteine concentrations
The complete blood count and serum iron, vitamin B12, folic acid, and homocysteine concentrations were determined by the routine tests performed in the Department of Laboratory Medicine of NTUH as described previously. 3,10,12e16 This study defined the Hb and hematinic deficiencies according to the World Health Organization (WHO) criteria. Thus, men with Hb < 13 g/dL and women with Hb < 12 g/dL were defined as having Hb deficiency or anemia. 20, 31 Patients with serum iron level <60 mg/dL, 32 vitamin B12 level <200 pg/mL 30 or folic acid level <4 ng/ mL 33 were defined as having iron, vitamin B12 or folic acid deficiency, respectively. Moreover, patients with the serum homocysteine level >12.3 mM (which was the mean serum homocysteine level of healthy control subjects plus two standard deviations) were defined as having abnormally high homocysteine level.
Determination of serum ANA, SMA, AMA, GPCA, TGA, and TMA levels
The methods of determination of serum ANA, SMA, AMA, GPCA, TGA, and TMA levels in our RAS patients and healthy control subjects have been described in our previous studies.
4,9e14,17
Statistical analysis
Comparisons of the mean MCV and mean blood levels of Hb, iron, vitamin B12, folic acid and homocysteine between any two of the four groups of GPCAþ/TGA/TMA/RAS patients, GPCAÀ/TGA/TMA/RAS patients, AbsÀ/RAS patients, and healthy control subjects were performed by Student's ttest. The differences in frequency of Hb, iron, vitamin B12 or folic acid deficiency, or frequency of abnormally high blood homocysteine level between any two of the four groups of GPCAþ/TGA/TMA/RAS patients, GPCAÀ/TGA/ TMA/RAS patients, AbsÀ/RAS patients, and healthy control subjects were compared by chi-square test. Comparisons of mean MCV and mean blood concentrations of Hb, iron, vitamin B12, folic acid and homocysteine between any two of the three groups of patients with macrocytic, normocytic or microcytic RBCs were performed by Student's t-test. The result was considered to be significant if the P-value was less than 0.05.
Results
The mean MCV and mean blood concentrations of Hb, iron, vitamin B12, folic acid, and homocysteine in 15 GPCAþ/ TGA/TMA/RAS patients, 69 GPCAÀ/TGA/TMA/RAS patients, 240 AbsÀ/RAS patients, and 342 healthy control subjects are shown in Table 1 . Because men usually had higher blood levels of Hb and iron than women, these two mean levels were calculated separately for men and women. We found significantly lower mean Hb (for men only, P < 0.001) and vitamin B12 (P < 0.001) levels as well as significantly higher mean blood homocysteine level (P < 0.001) in GPCAþ/TGA/ TMA/RAS patients than in healthy control subjects (Table  1) . Moreover, we found a lower mean vitamin B12 level (P Z 0.062, marginal significance), a higher mean MCV (P Z 0.059, marginal significance), and a significantly higher mean blood homocysteine level (P < 0.001) in GPCAþ/TGA/TMA/RAS patients than in GPCAÀ/TGA/TMA/ RAS patients. In addition, GPCAÀ/TGA/TMA/RAS patients had a significantly lower mean Hb (for men and women, both P-values < 0.001), lower mean MCV (P < 0.001), and lower mean iron (for men. P Z 0.018; for women, P < 0.001) than healthy control subjects. GPCAÀ/TGA/ TMA/RAS patients had a significantly higher mean Hb (for women only, both P Z 0.022) than AbsÀ/RAS patients. However, there were no significant differences in MCV and blood Hb (for men only), iron, vitamin B12, folic acid and homocysteine levels between GPCAÀ/TGA/TMA/RAS patients and AbsÀ/RAS patients. Furthermore, AbsÀ/RAS patients had significantly lower mean Hb (for men and women, both P-values < 0.001), MCV (P < 0.001), iron (for men and women, both P-values < 0.001), vitamin B12 (P Z 0.072, marginal significance), and folic acid levels (P Z 0.005) than healthy control subjects (Table 1) .
We also found significantly greater frequencies of Hb, iron and vitamin B12 deficiencies in GPCAþ/TGA/TMA/RAS, GPCAÀ/TGA/TMA/RAS, and AbsÀ/RAS patients as well as significantly greater frequencies of high blood homocysteine level in GPCAþ/TGA/TMA/RAS and AbsÀ/RAS patients than in healthy control subjects (all P-values < 0.001) ( Table 2 ). There were also significantly greater frequencies of vitamin B12 deficiency (P Z 0.014) and of high serum homocysteine level (P Z 0.001) in GPCAþ/TGA/TMA/RAS patients than in GPCAÀ/TGA/TMA/RAS patients. However, there were no significant differences in frequencies of blood Hb, iron, vitamin B12, folic acid deficiencies and of high serum homocysteine level between GPCAÀ/TGA/TMA/ RAS patients and AbsÀ/RAS patients.
In this study, 3 (20.0%) of 15 GPCAþ/TGA/TMA/RAS patients and 14 (20.3%) of 69 GPCAÀ/TGA/TMA/RAS patients were diagnosed as having anemia according to the WHO criteria (Table 3) . 31 The different anemia types of 3 anemic GPCAþ/TGA/TMA/RAS patients and of 14 anemic GPCAÀ/ TGA/TMA/RAS patients are described in detail in Table 3 . In this study, PA was diagnosed as having MCV S 100 fl, vitamin B12 < 200 pg/mL, and serum GPCA positivity, 17e19 iron deficiency anemia as having MCV <80 fl and iron <60 mg/dL 20, 31, 32 ; and thalassemia trait as having MCV <74 fl, RBC count >5.0 Â 10 12 /L, and Mentzer index (MCV/ RBC) < 13. 23 By these definitions, of 3 anemic GPCAþ/TGA/ TMA/RAS patients, 2 had PA and one had normocytic anemia. Moreover, of 14 anemic GPCAÀ/TGA/TMA/RAS patients, 2 had macrocytic anemia but not PA, 4 had normocytic anemia, 5 had iron deficiency anemia, 3 had thalassemia trait. When 15 GPCAþ/TGA/TMA/RAS patients were further divided into two groups: group 1 (2 patients with MCV S 100 fl) and group 2 (13 patients with MCV between 80 fl and 99.9 fl), we found that group 1 patients had Anemia in recurrent aphthous stomatitis 5 significantly higher MCV (P < 0.001), lower mean serum vitamin B12 level (P Z 0.076, marginal significance), and significantly higher mean serum homocysteine level (P Z 0.001) than group 2 patients (Table 4) . None of 15 GPCAþ/TGA/TMA/RAS patients had their MCV <80 fl (Table  4) . We also divided 69 GPCAÀ/TGA/TMA/RAS patients into three groups: group 1 (2 patients with MCV S 100 fl), group 2 (53 patients with MCV between 80 fl and 99.9 fl), and group 3 (14 patients with MCV < 80 fl). We found that group 1 patients had significantly higher MCV (P < 0.001), lower mean serum vitamin B12 level (P Z 0.017), and higher mean serum homocysteine level (P < 0.001) than group 2 patients (Table 5 ). Group 3 patients had significantly lower mean Hb level (for women only, P < 0.001), lower MCV (P < 0.001), and lower mean serum iron level (for women only, P Z 0.008) than group 2 patients (Table 5 ). Moreover, group 1 had significantly higher MCV (P < 0.001), lower mean serum vitamin B12 level (P Z 0.015), and higher mean serum homocysteine level (P < 0.001) than group 3 patients (Table 5) .
Discussion
This study found that GPCAþ/TGA/TMA/RAS patients had significantly lower mean Hb (for men only) and serum vitamin B12 levels as well as significantly higher mean serum homocysteine level than healthy control subjects. Moreover, GPCAþ/TGA/TMA/RAS patients had significantly greater frequencies of Hb, serum iron, and serum vitamin B12 deficiencies and of high serum homocysteine level than healthy control subjects. These two findings suggest that the anemia status and hematinic deficiencies in GPCAþ/ TGA/TMA/RAS patients may be attributed to serum GPCA positivity, TGA/TMA positivity, and/or the disease of RAS itself. To elucidate these equivocal probabilities, we compared the blood data between 15 GPCAþ/TGA/TMA/ RAS patients and 69 GPCAÀ/TGA/TMA/RAS patients. We found GPCAþ/TGA/TMA/RAS patients had lower serum vitamin B12 level, higher MCV, and significantly higher serum homocysteine level as well as significantly greater frequencies of vitamin B12 deficiency and of high serum homocysteine level than GPCAÀ/TGA/TMA/RAS patients. These findings indicate that the serum GPCA positivity play an important role in causing vitamin B12 deficiency, high MCV, and high homocysteine level in GPCAþ/TGA/TMA/RAS patients. Furthermore, this study also found that both GPCAÀ/TGA/TMA/RAS and AbsÀ/RAS patients did have significantly lower mean Hb, MCV, and serum iron levels as well as significantly greater frequencies of Hb, iron and vitamin B12 deficiencies than healthy control subjects. Female GPCAÀ/TGA/TMA/RAS patients had significantly higher mean Hb level than female AbsÀ/RAS patients. However, there were no significant differences in MCV and mean blood Hb (for men only), iron, vitamin B12, and folic acid, and homocysteine levels as well as in frequencies of blood Hb, iron, vitamin B12, and folic acid deficiencies and of high serum homocysteine level between GPCAÀ/TGA/ TMA/RAS patients and AbsÀ/RAS patients These findings indicate TGA/TMA positivity does not play a significant role in causing anemia and hematinic deficiencies in GPCAÀ/ TGA/TMA/RAS patients. We also found that AbsÀ/RAS patients did have significantly lower MCV and lower mean Table 5 The mean corpuscular volume (MCV) and mean blood concentrations of hemoglobin (Hb), iron, vitamin B12, folic acid, and homocysteine, in 69 anti-gastric parietal cell antibody (GPCA)-negative and anti-thyroglobulin antibody (TGA)/antithyroid microsomal antibody (TMA)-positive recurrent aphthous stomatitis (RAS) patients (GPCAÀ/TGA/TMA/RAS patients) including 2 with MCV S 100 fl (group 1), 53 with MCV between 80 fl and 99.9 fl (group 2), and 14 with MCV < 80 fl (group 3). GPCAÀ/TGA/TMA/RAS patients (n Z 69) blood Hb, iron, vitamin B12, and folic acid levels as well as significantly greater frequencies of Hb, iron, vitamin B12, and folic acid deficiencies and of high serum homocysteine level than healthy control subjects. These findings indicate that the disease of RAS itself does play a significant role in causing anemia and hematinic deficiencies in GPCAÀ/TGA/ TMA/RAS patients and AbsÀ/RAS patients. The serum GPCA can induce destruction of gastric parietal cells, resulting in failure of intrinsic factor production. 5, 6 Complete or partial loss of intrinsic factor causes vitamin B12 deficiency that finally leads to macrocytosis and the status of PA. 7, 8 Vitamin B12 and folic acid deficiencies can lead to high serum homocysteine level in oral mucosal disease patients. 3,10,14e16 However, supplementation of multiple B vitamins especially vitamin B12 and folic acid can reduce the serum homocysteine levels in patients with AG or BMS. 24, 34 Therefore, the higher frequency of vitamin B12 deficiency, higher MCV, and higher homocysteine level in GPCAþ/TGA/TMA/RAS patients than in healthy control patients are predominantly due to the presence of GPCA in GPCAþ/TGA/TMA/RAS patients' sera. Vitamin B12 deficiency can result in a significantly reduced production of Hb. 18 Moreover, deficiency of vitamin B12 inhibits purine and thymidylate syntheses, impairs DNA synthesis, and causes erythroblast apoptosis, leading to anemia from ineffective erythropoiesis. 35 Therefore, GPCAinduced vitamin B12 deficiency can at least partially explain why some of our GPCAþ/TGA/TMA/RAS patients have low Hb level and anemia.
We further explain why RAS itself may be an important factor causing anemia and hematinic deficiencies in RAS patients. A previous diet history questionnaire study showed a significantly lower daily intake of vitamin B12 and folate in minor-typed RAS patients than in control subjects. 36 This finding suggests that the frequent presence of single or multiple small oral ulcerations may result in a significantly lower daily intake of vitamin B12 and folate. By definition, the major-typed RAS patients often have severer and larger recurrent oral ulcerations than minor-typed RAS patients. 3 These severer ulcerative lesions may cause burning sensation and pain of the lesional oral mucosae when the patients eat salty and spicy food stuffs. The eating difficulty may lead to reduced food intake that in turn causes anemia and hematinic deficiencies in a certain percentage of our TGA/TMA/RAS patients.
In this study, 3 (20.0%) of the 15 GPCAþ/TGA/TMA/RAS patients and 14 (20.3%) of 69 GPCAÀ/TGA/TMA/RAS patients had anemia. 20, 31 Five types of anemia including pernicious, macrocytic, normocytic, or iron deficiency anemia and thalassemia trait were detected in our TGA/ TMA/RAS patients (Table 3 ). We also found that 2 of 2 PA patients (one patient had concomitant iron deficiency) and 2 of 2 macrocytic anemia patients had vitamin B12 but not folic acid deficiency, suggesting that these two types of anemia are predominantly due to vitamin B12 deficiency. Of 5 normocytic anemia patients, 4 (80.0%) had iron deficiency and one (20.0%) had vitamin B12 deficiency, indicating that normocytic anemia in our TGA/TMA/RAS patients are predominantly due to iron deficiency and secondarily due to vitamin B12 deficiency. In our 5 iron deficiency anemia patients, none had concomitant vitamin B12 and folic acid deficiencies. Furthermore, none of our 3 thalassemia trait patients had vitamin B12, iron or folic acid deficiency, indicating the Hb deficiency in thalassemia trait patients is merely due to gene mutation resulting in insufficient production of either the a-globin or b-globin chains of the Hb molecule. 23 Of the 15 GPCAþ/TGA/TMA/RAS patients, 2 (13.3%, group 1 patients) produced macrocytic RBCs and 13 (86.7%, group 2 patients) normocytic RBCs. We also found that 2 (40.0%) of 5 vitamin B12-deficient GPCAþ/TGA/TMA/RAS patients and 2 (100.0%) of 2 macrocytosis GPCAþ/TGA/ TMA/RAS patients had PA. Only one of 13 normocytosis GPCAþ/TGA/TMA/RAS patients had normocytic anemia. Of the 69 GPCAÀ/TGA/TMA/RAS patients, 2 (2.9%, group 1 patients) produced macrocytic RBCs, 53 (76.8%, group 2 patients) normocytic RBCs, and 14 (20.3%, group 3 patients) microcytic RBCs. Compared to group 2 patients, both groups 1 and 3 patients had relatively severe anemia, group 3 patients tended to have relatively low serum iron level (for women only), group 1 patients usually had low serum vitamin B12 level and significantly high blood homocysteine level, and group 3 patients usually had no vitamin B12 and folic acid deficiencies. These findings also prove the intimate association of vitamin B12 deficiency with macrocytosis and abnormally high serum homocysteine level as well as the close relation between iron deficiency and microcytosis in our TGA/TMA/RAS patients.
We conclude that both serum GPCA positivity and RAS itself are the contributing factors causing anemia and hematinic deficiencies in GPCAþ/TGA/TMA/RAS patients. Serum GPCA is the major factor causing vitamin B12 deficiency, macrocytosis and pernicious anemia in GPCAþ/ TGA/TMA/RAS patients. TGA/TMA positivity does not play a significant role causing anemia and hematinic deficiencies in both GPCAþ/TGA/TMA/RAS and GPCAÀ/TGA/TMA/RAS patients. RAS itself does play a significant role in causing anemia and hematinic deficiencies in GPCAÀ/TGA/TMA/ RAS and AbsÀ/RAS patients.
